Skip to Main Content

Paper Details

Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics.
Mol Cancer Ther
19
2019
Author NameAffiliation
Paul T FantaCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, university of california san diego Moores Cancer Center
Scott M LippmanCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, university of california san diego Moores Cancer Center
  • 1 - 2

Datasets

Release 1.2